IGBA: Global Roadmap for Tailored Clinical Biosimilar Development: Instrumental for Sustainable Access to Biologics

24 September 2020

Joint press statement of European Pharmaceutical industry associations

17 September 2020

Decisive action on medicines shortages should be included in pharmaceutical and industrial strategies

17 September 2020

Practical measures are paramount for robust medicines manufacturing

9 September 2020

Interview: Medicines for Europe Reports on EU Biosimilar Success

27 July 2020

The Center for Biosimilars® (CfB) spoke with Adrian van den Hoven, […]

Christoph Stoller and Adrian van den Hoven interviewed by PharmaBoardroom

17 July 2020

In the wake of the publication of Medicines for Europe’s Lessons […]

Resolving and mitigating medicine shortages in the EU

10 February 2020

Drug shortages can greatly impact patients and the pharmaceutical industry. […]

Arun Narayan – Chairman, Value Added Medicines Group, Medicines for Europe

31 January 2020

Arun Narayan is the Chairman of the Value Added Medicines […]

Biosimilar Uptake in Europe: Big Challenges; Bigger Rewards

16 January 2020

Since the first treatment was approved in 2006, Europe has […]

Biosimilars ‒ Policy failings that deny savings to countries that need it most

21 November 2019